NCT06744946View on ClinicalTrials.gov

Thoracoscopic Talc Pleurodesis Versus Bleomycin -Tranxemic Acid Mixture Injection in Chest Tube in Malignant Pleural Effusion

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

October 29, 2024

Study Completion Date

December 4, 2024

Conditions
Malignant Pleural Effusions (Mpe)- PleurodesisPleurodesis
Interventions
PROCEDURE

thoracoscope

bleomycin- tranxemic acid mixture pleurodesis versus thoracoscopic talc poudrage

Trial Locations (1)

11521

Chest Department -Faculty of Medicine, Alexandria

All Listed Sponsors
collaborator

Alexandria University

OTHER

lead

Mohamed Sabry

OTHER

NCT06744946 - Thoracoscopic Talc Pleurodesis Versus Bleomycin -Tranxemic Acid Mixture Injection in Chest Tube in Malignant Pleural Effusion | Biotech Hunter | Biotech Hunter